Accessibility Menu
Renalytix Plc logo

Renalytix Plc

(LSE) RENX

Current Price£0.02
Market Cap£8.08M
Since IPO (2018)-98%
5 Year-100%
1 Year-74%
1 Month+3%

Renalytix Plc Financials at a Glance

Market Cap

£8.08M

Revenue (TTM)

$2.37M

Net Income (TTM)

-$23.43M

EPS (TTM)

£0.00

P/E Ratio

-0.13

Dividend

£0.00

Beta (Volatility)

0.07 (Low)

Price

£0.02

Volume

303,530

Open

£0.02

Previous Close

£0.02

Daily Range

£0.02 - £0.02

52-Week Range

£0.02 - £0.16

Estimated Earnings Date

Nov 3, 2026

RENX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Renalytix Plc

Industry

Health Care Technology

Employees

46

CEO

James Renwick McCullough, MBA

Headquarters

New York City, NY 10036, US

RENX Financials

Key Financial Metrics (TTM)

Gross Margin

7%

Operating Margin

-13%

Net Income Margin

-15%

Return on Equity

0%

Return on Capital

8%

Return on Assets

-4%

Earnings Yield

-7.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£8.08M

Shares Outstanding

437.02M

Volume

303.53K

Avg. Volume

835.70K

Financials (TTM)

Gross Profit

$1.20M

Operating Income

-$17.20M

EBITDA

-$21.30M

Operating Cash Flow

-$17.90M

Capital Expenditure

$0.00

Free Cash Flow

-$17.90M

Cash & ST Invst.

$3.70M

Total Debt

$8.30M

Renalytix Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$729.00K

+2.8%

Gross Profit

$398.00K

+73.8%

Gross Margin

54.60%

N/A

Market Cap

£8.08M

N/A

Market Cap/Employee

£79.26K

N/A

Employees

102

N/A

Net Income

-$3.88M

+54.2%

EBITDA

-$7.50M

+8.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$6.20M

+31.8%

Total Debt

$5.80M

-38.4%

Accounts Receivable

$1.30M

+134.7%

Inventory

$300.00K

N/A

Long Term Debt

$5.60M

+14.5%

Short Term Debt

$200.00K

-95.6%

Return on Assets

-4.20%

N/A

Return on Invested Capital

8.40%

N/A

Free Cash Flow

-$6.50M

+18.0%

Operating Cash Flow

-$6.50M

+18.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
POLB.LPoolbeg Pharma PLC
£0.08+4.58%
SAR.LSareum Holdings plc
£0.24+4.35%
NCYT.LNovacyt S.A.
£0.36-2.47%
IHC.LInspiration Healthcare Group plc
£0.27+3.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$29.27-0.28%
AALAmerican Airlines Group
$13.42-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.25+0.06%
INTCIntel
$107.04-0.01%

Questions About RENX

What is the current price of Renalytix Plc?

Renalytix Plc is trading at £0.02 per share.

What is the 52-week range for Renalytix Plc?

Over the past 52 weeks, Renalytix Plc has traded between £0.02 and £0.16.

How much debt does Renalytix Plc have?

As of the most recent reporting period, Renalytix Plc reported total debt of $6.55M.

How much cash does Renalytix Plc have on hand?

Renalytix Plc reported $7.35M in cash and cash equivalents in its most recent financial results.

What is Renalytix Plc’s dividend yield?

Renalytix Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.